Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ZBIO

Zenas BioPharma, Inc.

CIK 0001953926 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$29.43
↑ 0.66 (2.31%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Options

Key stats

Market Cap
$1.86B
P/E Ratio
-4.37
EPS
-8.44
Dividend Yield
Not covered
52W Position
56%
Beta
1.07

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
5.53
P/S
Not covered
EV/Revenue
Not covered
ROE
-126.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 56%
$9.98$44.60

Latest Financials

2025-12-31 FY
Revenue
$10.00M
Net Income
-$377.74M
Total Assets
$383.64M
Free Cash Flow
-$172.35M

Recent news